Martin Baron

Title: Martin Baron: Innovator in Fibrin-Binding Peptides

Introduction

Martin Baron is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biochemistry, particularly in the development of fibrin-binding peptide fragments of fibronectin. His work has implications for diagnosing and treating various medical conditions.

Latest Patents

Martin Baron holds a patent for "Fibrin-binding peptide fragments of fibronectin." This patent describes fibrin-binding molecules that include peptide sequences corresponding to specific portions of the natural fibronectin molecule. The first portion includes the F1 module pair of fibronectin, while the second portion includes the F1 module pair of fibronectin as well. The patent also covers nucleic acid molecules encoding these peptides, methods for their production, and their applications in diagnosing and treating conditions associated with fibrin deposition.

Career Highlights

Throughout his career, Martin Baron has worked with prestigious institutions, including New York University and Isis Innovation Limited. His research has focused on the intersection of biochemistry and medical applications, leading to advancements in the understanding of fibrin-related conditions.

Collaborations

Martin Baron has collaborated with esteemed colleagues, including Leslie I Gold and Michael J Williams. These partnerships have contributed to the depth and breadth of his research in the field.

Conclusion

Martin Baron is a distinguished inventor whose work on fibrin-binding peptides has the potential to impact medical diagnostics and treatments significantly. His contributions to the field of biochemistry continue to inspire future innovations.